JNJ: Johnson & Johnson Stocks News on July 10, 2025

JNJ

MT Newswires

11 hours ago

Morgan Stanley Adjusts PT on Johnson & Johnson to $171 From $169, Maintains Equalweight Rating

Factbox-Major deals involving U.S. drugmakers and biotechs over the past decade

JNJ

Reuters

a day ago

Factbox-Major deals involving U.S. drugmakers and biotechs over the past decade

Wall Street waves off Trump's 200% pharma tariff threat

JNJ

Yahoo Finance

a day ago

Wall Street waves off Trump's 200% pharma tariff threat

JNJ

MT Newswires

a day ago

Johnson & Johnson's Q2 Earnings Call Likely to Focus on Guidance, Tariff Impact, BofA Says

Johnson & Johnson (JNJ) Expected to Beat Earnings Estimates: Should You Buy?

JNJ

Zacks

a day ago

Johnson & Johnson (JNJ) Expected to Beat Earnings Estimates: Should You Buy?

Why Johnson & Johnson (JNJ) is a Top Value Stock for the Long-Term

JNJ

Zacks

a day ago

Why Johnson & Johnson (JNJ) is a Top Value Stock for the Long-Term

Merck Faces Multiple Challenges: Will It Steer Through Successfully?

JNJ

Zacks

a day ago

Merck Faces Multiple Challenges: Will It Steer Through Successfully?

JNJ vs. Pfizer: Which Pharma Giant is the Better Investment Now?

JNJ

Zacks

a day ago

JNJ vs. Pfizer: Which Pharma Giant is the Better Investment Now?

SpaceX Just Made Elon Musk $20 Billion Richer

JNJ

Barrons.com

a day ago

SpaceX Just Made Elon Musk $20 Billion Richer

Glaukos Ramps Up iDose TR, Battles Legacy and Reimbursement Risks

JNJ

Zacks

a day ago

Glaukos Ramps Up iDose TR, Battles Legacy and Reimbursement Risks

Johnson & Johnson (JNJ) Applied to the European Medicines Agency to Expand AKEEGA Usage

JNJ

Insider Monkey

2 days ago

Johnson & Johnson (JNJ) Applied to the European Medicines Agency to Expand AKEEGA Usage

JNJ

MT Newswires

2 days ago

Pharma Stocks Pare Gains After Trump Reportedly Threatens 200% Tariff on Imported Drugs

Johnson & Johnson (NYSE:JNJ) Submits sNDA For Schizophrenia Drug CAPLYTA® To FDA

JNJ

Simply Wall St.

2 days ago

Johnson & Johnson (NYSE:JNJ) Submits sNDA For Schizophrenia Drug CAPLYTA® To FDA

JNJ

MT Newswires

2 days ago

Sector Update: Health Care Stocks Steady Premarket Tuesday

JNJ

MT Newswires

2 days ago

Johnson & Johnson Submits Supplemental NDA for Schizophrenia Treatment Caplyta

How Will Skyrizi and Rinvoq Sales Aid AbbVie's Upcoming Q2 Results?

JNJ

Zacks

2 days ago

How Will Skyrizi and Rinvoq Sales Aid AbbVie's Upcoming Q2 Results?

Supplemental new drug application submitted to U.S. FDA for CAPLYTA® (lumateperone) with data demonstrating significant schizophrenia relapse prevention compared to placebo

JNJ

PR Newswire

2 days ago

Supplemental new drug application submitted to U.S. FDA for CAPLYTA® (lumateperone) with data demonstrating significant schizophrenia relapse prevention compared to placebo

Analysis: 'Trump Effect' website takes credit for US investment made under Biden

JNJ

Reuters

2 days ago

Analysis: 'Trump Effect' website takes credit for US investment made under Biden

Here's Why Johnson & Johnson (JNJ) is a Strong Momentum Stock

JNJ

Zacks

3 days ago

Here's Why Johnson & Johnson (JNJ) is a Strong Momentum Stock

Will J&J's Q2 Results Reflect End of MedTech Issues & Higher Sales?

JNJ

Zacks

3 days ago

Will J&J's Q2 Results Reflect End of MedTech Issues & Higher Sales?

J&J’s Abiomed recalls heart pump controllers after 3 patients die

JNJ

MedTech Dive

3 days ago

J&J’s Abiomed recalls heart pump controllers after 3 patients die

Should You Forget Johnson & Johnson and Buy This Magnificent High-Yield Dividend Stock Instead?

JNJ

Motley Fool

3 days ago

Should You Forget Johnson & Johnson and Buy This Magnificent High-Yield Dividend Stock Instead?

J.P. Morgan Maintained Their Hold Rating on Johnson & Johnson (JNJ)

JNJ

Insider Monkey

5 days ago

J.P. Morgan Maintained Their Hold Rating on Johnson & Johnson (JNJ)

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

JNJ

Zacks

6 days ago

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

North America Beta-Glucan Market Forecast and Company Analysis Report 2025-2033 Featuring Koninklijke Philips, EDAP TMS, Johnson & Johnson, Medtronic, Hitachi, Theraclion, Stryker, and GE

JNJ

GlobeNewswire

7 days ago

North America Beta-Glucan Market Forecast and Company Analysis Report 2025-2033 Featuring Koninklijke Philips, EDAP TMS, Johnson & Johnson, Medtronic, Hitachi, Theraclion, Stryker, and GE

Goldman Sachs Rates Johnson & Johnson a Buy, Citing Pipeline Strength and Policy Tailwinds

JNJ

Insider Monkey

7 days ago

Goldman Sachs Rates Johnson & Johnson a Buy, Citing Pipeline Strength and Policy Tailwinds

Why Johnson & Johnson (JNJ) Could Beat Earnings Estimates Again

JNJ

Zacks

7 days ago

Why Johnson & Johnson (JNJ) Could Beat Earnings Estimates Again

Johnson & Johnson (JNJ) Could Be a Great Choice

JNJ

Zacks

7 days ago

Johnson & Johnson (JNJ) Could Be a Great Choice

JNJ

MT Newswires

7 days ago

Johnson & Johnson Unit Submits EMA Application to Extend Indication of Akeega for Prostate Cancer

JNJ

Zacks

7 days ago

The Zacks Analyst Blog Highlights Johnson & Johnson, The Home Depot, Micron Technology, Autoscope Technologies and Nova LifeStyle

Is Most-Watched Stock Johnson & Johnson (JNJ) Worth Betting on Now?

JNJ

Zacks

7 days ago

Is Most-Watched Stock Johnson & Johnson (JNJ) Worth Betting on Now?

Johnson & Johnson submits application to the European Medicines Agency seeking indication extension of AKEEGA® (niraparib and abiraterone acetate dual action tablet) for the treatment of adult patients with metastatic hormone-sensitive prostate cancer and HRR gene alterations

JNJ

GlobeNewswire

7 days ago

Johnson & Johnson submits application to the European Medicines Agency seeking indication extension of AKEEGA® (niraparib and abiraterone acetate dual action tablet) for the treatment of adult patients with metastatic hormone-sensitive prostate cancer and HRR gene alterations

MRK Pins Hopes on New PAH Drug Winrevair Amid Looming Keytruda LOE

JNJ

Zacks

7 days ago

MRK Pins Hopes on New PAH Drug Winrevair Amid Looming Keytruda LOE

Regeneron nabs dosing edge with Lynozyfic’s FDA approval in multiple myeloma

JNJ

Pharmaceutical Technology

7 days ago

Regeneron nabs dosing edge with Lynozyfic’s FDA approval in multiple myeloma

Top Analyst Reports for Johnson & Johnson, Home Depot and Micron

JNJ

Zacks

8 days ago

Top Analyst Reports for Johnson & Johnson, Home Depot and Micron

Does J&J's Innovative Medicine Unit Hold the Key to Q2 Sales Growth?

JNJ

Zacks

8 days ago

Does J&J's Innovative Medicine Unit Hold the Key to Q2 Sales Growth?

Johnson & Johnson (JNJ) Rises As Market Takes a Dip: Key Facts

JNJ

Zacks

9 days ago

Johnson & Johnson (JNJ) Rises As Market Takes a Dip: Key Facts

A Promising Depression Drug Works. Psychedelics Are Back.

JNJ

Barrons.com

9 days ago

A Promising Depression Drug Works. Psychedelics Are Back.

Should You Invest in the Fidelity MSCI Health Care Index ETF (FHLC)?

JNJ

Zacks

9 days ago

Should You Invest in the Fidelity MSCI Health Care Index ETF (FHLC)?

Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?

JNJ

Zacks

9 days ago

Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?

Should iShares Core High Dividend ETF (HDV) Be on Your Investing Radar?

JNJ

Zacks

9 days ago

Should iShares Core High Dividend ETF (HDV) Be on Your Investing Radar?

PJM Appoints Deena O'Brien as Senior Director of Communications

JNJ

PR Newswire

10 days ago

PJM Appoints Deena O'Brien as Senior Director of Communications

The Hackett Group® Announces Winners of the 2025 Hackett Innovation Awards

JNJ

Business Wire

10 days ago

The Hackett Group® Announces Winners of the 2025 Hackett Innovation Awards

Oncolytics Biotech® Appoints Former Ambrx Executive as Chief Business Officer to Drive Business Development Strategy

JNJ

CNW Group

10 days ago

Oncolytics Biotech® Appoints Former Ambrx Executive as Chief Business Officer to Drive Business Development Strategy

Johnson & Johnson’s (JNJ) IMAAVY Demonstrates Superior gMG Control

JNJ

Insider Monkey

12 days ago

Johnson & Johnson’s (JNJ) IMAAVY Demonstrates Superior gMG Control

Here's What to Expect From Johnson & Johnson's Next Earnings Report

JNJ

Barchart

13 days ago

Here's What to Expect From Johnson & Johnson's Next Earnings Report

Want Decades of Passive Income? 5 Stocks to Buy Now and Hold Forever

JNJ

Motley Fool

14 days ago

Want Decades of Passive Income? 5 Stocks to Buy Now and Hold Forever

Retinitis Pigmentosa Research Report 2025: $25+ Bn Market Opportunities and Strategies to 2034 - Gene Therapy Poised as Fastest Growing Treatment Segment, Strategic Collaborations Drive Advancements

JNJ

GlobeNewswire

14 days ago

Retinitis Pigmentosa Research Report 2025: $25+ Bn Market Opportunities and Strategies to 2034 - Gene Therapy Poised as Fastest Growing Treatment Segment, Strategic Collaborations Drive Advancements

Johnson & Johnson CAR T Therapy Shows 80% Response in Lymphoma Trial

JNJ

Insider Monkey

15 days ago

Johnson & Johnson CAR T Therapy Shows 80% Response in Lymphoma Trial

Johnson & Johnson (JNJ) Launches Two New Plating Systems in the US

JNJ

Insider Monkey

16 days ago

Johnson & Johnson (JNJ) Launches Two New Plating Systems in the US

Johnson & Johnson MedTech Expands VOLT Platform With New Wrist, Upper Arm Fracture Systems

JNJ

Insider Monkey

16 days ago

Johnson & Johnson MedTech Expands VOLT Platform With New Wrist, Upper Arm Fracture Systems

J&J (JNJ) Faces $8M Verdict Over Talc Case; Stock Still Gains 4.66% YTD

JNJ

Insider Monkey

16 days ago

J&J (JNJ) Faces $8M Verdict Over Talc Case; Stock Still Gains 4.66% YTD

Johnson & Johnson announces new data presented at EAN of IMAAVY

JNJ

TipRanks

16 days ago

Johnson & Johnson announces new data presented at EAN of IMAAVY

MRK's Winrevair Phase III Study in Newly Diagnosed PAH Meets Goal

JNJ

Zacks

16 days ago

MRK's Winrevair Phase III Study in Newly Diagnosed PAH Meets Goal

Pfizer to Face Several Headwinds: Can It Successfully Navigate Them?

JNJ

Zacks

16 days ago

Pfizer to Face Several Headwinds: Can It Successfully Navigate Them?

5 Dividend Stocks Poised to Profit From the AI Efficiency Boom

JNJ

Motley Fool

16 days ago

5 Dividend Stocks Poised to Profit From the AI Efficiency Boom

J&J introduces disposable contact lens for astigmatism and presbyopia

JNJ

Medical Device Network

16 days ago

J&J introduces disposable contact lens for astigmatism and presbyopia

Compass’s Psychedelic Drug to Treat Depression Meets Goal in Trial

JNJ

Bloomberg

17 days ago

Compass’s Psychedelic Drug to Treat Depression Meets Goal in Trial

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

JNJ

Zacks

17 days ago

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

J&J Adds More Than $15B in Six Months: How to Play JNJ Stock?

JNJ

Zacks

17 days ago

J&J Adds More Than $15B in Six Months: How to Play JNJ Stock?

J&J's Drugs Get CHMP Recommendations for Blood Cancer Indications

JNJ

Zacks

17 days ago

J&J's Drugs Get CHMP Recommendations for Blood Cancer Indications

JNJ

MT Newswires

17 days ago

Johnson & Johnson's Imaavy Shows 'Significant Improvement' Over Other Treatments for Autoimmune Disorder

Johnson & Johnson Launches First and Only Daily Disposable Multifocal Toric Contact Lens - ACUVUE OASYS MAX 1-Day MULTIFOCAL for ASTIGMATISM

JNJ

PR Newswire

17 days ago

Johnson & Johnson Launches First and Only Daily Disposable Multifocal Toric Contact Lens - ACUVUE OASYS MAX 1-Day MULTIFOCAL for ASTIGMATISM

IMAAVY™ (nipocalimab-aahu) showed greater sustained disease control versus approved FcRn blockers for generalized myasthenia gravis (gMG) at multiple timepoints over 24 weeks in newly published indirect treatment comparison (ITC)

JNJ

PR Newswire

17 days ago

IMAAVY™ (nipocalimab-aahu) showed greater sustained disease control versus approved FcRn blockers for generalized myasthenia gravis (gMG) at multiple timepoints over 24 weeks in newly published indirect treatment comparison (ITC)

JNJ

Zacks

18 days ago

Zacks Investment Ideas feature highlights: Jabil, Apple, Amazon, Johnson & Johnson and Ericsson

Mark Cuban Corrects Elizabeth Warren As She Slams JNJ, PFE For Higher Prices And Zero Taxes On Big Pharma: 'PBMs Corrupt Healthcare'

JNJ

Benzinga

19 days ago

Mark Cuban Corrects Elizabeth Warren As She Slams JNJ, PFE For Higher Prices And Zero Taxes On Big Pharma: 'PBMs Corrupt Healthcare'

JNJ’s Consistent Payout Makes It a Top Pick for Down Markets

JNJ

Insider Monkey

20 days ago

JNJ’s Consistent Payout Makes It a Top Pick for Down Markets

IMBRUVICA® (ibrutinib) receives positive CHMP opinion for the treatment of patients with previously untreated mantle cell lymphoma (MCL) who would be eligible for autologous stem cell transplant

JNJ

GlobeNewswire

20 days ago

IMBRUVICA® (ibrutinib) receives positive CHMP opinion for the treatment of patients with previously untreated mantle cell lymphoma (MCL) who would be eligible for autologous stem cell transplant

Johnson & Johnson (NYSE:JNJ) Faces US$8 Million Verdict Over Talcum Powder Cancer Case

JNJ

Simply Wall St.

21 days ago

Johnson & Johnson (NYSE:JNJ) Faces US$8 Million Verdict Over Talcum Powder Cancer Case

$J&J MedTech introduces new plates for VOLT fracture management platform$

JNJ

Medical Device Network

21 days ago

J&J MedTech introduces new plates for VOLT fracture management platform

Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know

JNJ

Zacks

21 days ago

Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know

Trump administration weighs crackdown on pharma ads, Bloomberg says

JNJ

TipRanks

22 days ago

Trump administration weighs crackdown on pharma ads, Bloomberg says

Should You Invest in the Invesco Pharmaceuticals ETF (PJP)?

JNJ

Zacks

22 days ago

Should You Invest in the Invesco Pharmaceuticals ETF (PJP)?

Johnson & Johnson rolls out TECNIS Odyssey IOL in selected regions

JNJ

Medical Device Network

23 days ago

Johnson & Johnson rolls out TECNIS Odyssey IOL in selected regions

JNJ

Motley Fool

23 days ago

2 Dividend Stocks to Buy and Never Sell

Move Over Hims & Hers Health: This Insurance Business Could Be the Next Monster Healthcare Stock (Hint: It's Not UnitedHealth)

JNJ

Motley Fool

23 days ago

Move Over Hims & Hers Health: This Insurance Business Could Be the Next Monster Healthcare Stock (Hint: It's Not UnitedHealth)

Trump's big beautiful bill: What the pharma industry is watching

JNJ

Yahoo Finance Video

23 days ago

Trump's big beautiful bill: What the pharma industry is watching

Johnson & Johnson’s Q1 Earnings Call: Our Top 5 Analyst Questions

JNJ

StockStory

23 days ago

Johnson & Johnson’s Q1 Earnings Call: Our Top 5 Analyst Questions

JNJ

MT Newswires

23 days ago

Market Chatter: Trump Administration to Consider Pharma Advertising Crackdown

ISRG's Minimally Invasive Ecosystem Powers Surgical Precision

JNJ

Zacks

23 days ago

ISRG's Minimally Invasive Ecosystem Powers Surgical Precision

Johnson & Johnson (JNJ) Stock Sinks As Market Gains: What You Should Know

JNJ

Zacks

24 days ago

Johnson & Johnson (JNJ) Stock Sinks As Market Gains: What You Should Know

Can J&J's Innovative Medicines Unit Sustain Growth Amid Stelara LOE?

JNJ

Zacks

24 days ago

Can J&J's Innovative Medicines Unit Sustain Growth Amid Stelara LOE?

J&J reports results from antibody combo trial for MM patients

JNJ

Clinical Trials Arena

24 days ago

J&J reports results from antibody combo trial for MM patients

JNJ

MT Newswires

25 days ago

Johnson & Johnson Says Drug Combo Study Shows 'Deep, Durable' Responses Multiple Myeloma Patients With Extramedullary Disease

Pharma manufacturing 'boom' faces high costs, potential delays

JNJ

Yahoo Finance

25 days ago

Pharma manufacturing 'boom' faces high costs, potential delays

Investigational combination of first-in-class bispecifics TALVEY® and TECVAYLI® shows deep and durable responses in heavily pretreated multiple myeloma patients with extramedullary disease

JNJ

PR Newswire

a month ago

Investigational combination of first-in-class bispecifics TALVEY® and TECVAYLI® shows deep and durable responses in heavily pretreated multiple myeloma patients with extramedullary disease

Johnson & Johnson (NYSE:JNJ) Unveils Promising CAR T-Cell Therapy for B-Cell Lymphoma

JNJ

Simply Wall St.

a month ago

Johnson & Johnson (NYSE:JNJ) Unveils Promising CAR T-Cell Therapy for B-Cell Lymphoma

UBS Backs Johnson & Johnson as a Defensive Play in Uncertain Times

JNJ

Insider Monkey

a month ago

UBS Backs Johnson & Johnson as a Defensive Play in Uncertain Times

Healthcare Sector Taps AI Boom via Intuitive Surgical Stock (ISRG)

JNJ

TipRanks

a month ago

Healthcare Sector Taps AI Boom via Intuitive Surgical Stock (ISRG)

JNJ

MT Newswires

a month ago

Sector Update: Health Care Stocks Softer Friday Afternoon

Senators to propose ban on drug ads to consumers, WSJ reports

JNJ

TipRanks

a month ago

Senators to propose ban on drug ads to consumers, WSJ reports

JNJ

MT Newswires

a month ago

Johnson & Johnson Says Therapy Shows 'Encouraging' First Trial Results in Large B-cell Lymphoma

JPMorgan biotech/pharma analysts hold analyst/industry conference call

JNJ

TipRanks

a month ago

JPMorgan biotech/pharma analysts hold analyst/industry conference call

Johnson & Johnson announces new Phase 1b data on bleximenib

JNJ

TipRanks

a month ago

Johnson & Johnson announces new Phase 1b data on bleximenib

Johnson & Johnson's dual-targeting CAR T-cell therapy shows encouraging first results in large B-cell lymphoma

JNJ

PR Newswire

a month ago

Johnson & Johnson's dual-targeting CAR T-cell therapy shows encouraging first results in large B-cell lymphoma

BSX Q1 Endoscopy Sales Rise 6%: What's Behind the Growth?

JNJ

Zacks

a month ago

BSX Q1 Endoscopy Sales Rise 6%: What's Behind the Growth?

Should You Forget Johnson & Johnson and Buy This Magnificent High-Yield Stock Instead?

JNJ

Motley Fool

a month ago

Should You Forget Johnson & Johnson and Buy This Magnificent High-Yield Stock Instead?

JNJ

MT Newswires

a month ago

Johnson & Johnson Says Phase 1b Trial Shows Promise for Bleximenib Combo in AML Treatment

New results for Johnson & Johnson's bleximenib demonstrate promising antileukemic activity in combination with venetoclax and azacitidine for acute myeloid leukemia

JNJ

PR Newswire

a month ago

New results for Johnson & Johnson's bleximenib demonstrate promising antileukemic activity in combination with venetoclax and azacitidine for acute myeloid leukemia

J&J’s Tremfya reduces active psoriatic arthritis symptoms in Phase IIIb trial

JNJ

Clinical Trials Arena

a month ago

Latest Johnson & Johnson (JNJ) News on July 10, 2025

Share on Social Networks: